Team
Stress and cancer
To top
Team
FATIMA MECHTA-GRIGORIOU
Stress and cancer
Members
News
All news
-
Triple-negative breast cancer : First patients included in a clinical trial at Institut CurieTriple-negative breast cancers represent about 15% of cases, affect younger women more and remain difficult to treat. The new "Skyline" clinical trial, which has just opened as part of the RHU CASSIOPEIA Future Investment Program at Institut Curie, the 1st European center for breast cancer management, has a double objective: to evaluate the effectiveness of a new combination of two immunotherapies in combination with chemotherapy in women with triple-negative breast cancer and to better visualize the cancer and its possible metastases thanks to innovative imaging used for the first time in France.15/04/2024
-
World Triple Negative Breast Cancer Day: innovation to cure more womenWorld Triple Negative Breast Cancer Day, held on March 3rd, is a reminder that triple-negative breast cancers remain the most difficult to treat, and that only innovation and dynamic research can bring hope of curing more patients.01/03/2024
-
New therapeutic avenues to improve the treatment of ovarian cancerBy studying for the first time the effects of chemotherapy on certain cells of the tumor microenvironment, a team from Institut Curie and Inserm led by Dr. Fatima Mechta-Grigoriou is taking a step forward in understanding the mechanisms of resistance to chemotherapy in patients with ovarian cancer. Indeed, scientists have managed to identify a population of fibroblasts (support cells) capable of inhibiting the antitumor action of certain immune cells even after treatment. Published in Nature Communications, these results open the way to potential anti-cancer therapeutic applications.22/02/2024
-
Dr. Fatima Mechta-Grigoriou, winner of the Duquesne award 2023Dr. Fatima Mechta-Grigoriou, Deputy Director of the Cancer, Heterogeneity, Instability and Plasticity unit - CHIP, and head of the Stress and Cancer team wins the Prix Duquesne 2023 for her promising research on fibroblasts in cancer.19/09/2023
-
Journée mondiale de la Propriété Intellectuelle : les femmes mises à l’honneurEn cette Journée de la Propriété Intellectuelle 2023 sont célébrées la créativité et l'innovation des femmes inventrices et entrepreneuses au bénéfice de la société et de l’économie, pour lutter contre les inégalités existantes dans ces secteurs. L’occasion pour l’Institut Curie de mettre en lumière le parcours du Dr Stéphanie Descroix, directrice de recherche CNRS à l’Institut Curie, engagée sur tous les fronts de l’innovation.25/04/2023
-
L’Institut Curie, catalyseur d’innovation avec 101 inventeurs à son actifEn cette journée mondiale de l’inventeur, l’Institut Curie salue ses 101 salariés inventeurs comptabilisés en 2022. Un chiffre impressionnant qui traduit l’engagement de l’Institut Curie à encourager l’innovation auprès de ses collaborateurs, ainsi que l’excellence et l’inventivité des travaux des chercheurs, médecins et soignants, au bénéfice des patients.08/11/2022